Evidence Summary
- Evidence Level
- Moderate
- Mechanism
- Enrollment: Actual, Sponsor Type: Other, Unknown / General
- Safety
- Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
- Dosing
- See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 3 associated trial(s) and 0 study reference(s) in current data. Review primary sources and consult specialists before use.
Clinical Trials
3 trial(s) registered
| NCT ID | Title | Phase | Status |
|---|---|---|---|
| NCT01584934 | Sodium Oxybate in Patients With Chronic Fatigue Syndrome. | Phase 4 | Withdrawn |
| NCT02055898 | SWS And Daytime Functioning in Chronic FatiguE Syndrome (SAFFE) | Phase 4 | Completed |
| NCT00498485 | Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome | Phase 4 | Terminated |
Key Studies / References
- See linked studies